Can Ezetimibe with a statin shrink heart artery plaque more?

The two-drug treatment reduced heart artery plaque more than one drug alone over 18 months, according to the report. The study compared Ezetimibe plus rosuvastatin with atorvastatin alone. Rosuvastatin and atorvastatin are Statins, drugs that lower cholesterol production in the liver. Ezetimibe works differently: it reduces how much cholesterol the gut absorbs. The two treatments therefore target different sources of cholesterol. People in the study had scans of their heart arteries before treatment. They had repeat scans at 9 months and 18 months. These measured plaque, the buildup inside artery walls. The supplied excerpt does not give people's ages or the study's size. The combination group also had a much larger drop in LDL Cholesterol. This is often called bad cholesterol. However, the excerpt gives no starting levels, final levels, or percentage changes. It also gives no numbers for how much plaque shrank. That means we can describe the direction of the results, but not their size. One detail matters: the groups took different statin drugs. This was not the same drug with and without Ezetimibe. The comparison cannot tell us how much of the difference came from Ezetimibe alone. For BioSocial members, this offers a useful way to frame shared bloodwork. Your starting number, treatment names, and test dates add context to any change. Comparing those details with community peers is more useful than comparing final numbers alone. Bloodwork and artery scans also measure different things; this report tracked both. What changes have you seen in your LDL Cholesterol while taking Ezetimibe, and over what time frame?